Who is the CEO of VectorB2B - Drug Development?

Ana Custódio serves as the Co-CEO of VectorB2B.

How many employees does VectorB2B - Drug Development have?

VectorB2B has a team of more than 15 people.

Where is VectorB2B - Drug Development headquartered?

VectorB2B is located in Portugal.

What industry is VectorB2B - Drug Development in?

VectorB2B - Drug Development operates in Biotechnology / Drug Development.

When was VectorB2B - Drug Development founded?

VectorB2B - Drug Development was founded in 2019.

Is VectorB2B - Drug Development still active?

Yes, VectorB2B - Drug Development was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.

How do I sell to VectorB2B - Drug Development?

Research VectorB2B - Drug Development's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details.

Data Surfer

How it works Insights Pricing FAQ Contact Login

VectorB2B - Drug Development

Biotechnology / Drug Development

Portugal

29 employees

Founded 2019

vectorb2b.com

Verified active February 2, 2026

Key Highlights

VectorB2B is a Portuguese non-profit association focused on accelerating drug development through specialized services.
The organization provides comprehensive pre-clinical and clinical development services for the pharmaceutical industry.
VectorB2B supports companies across their entire R&D journey, from initial discovery to clinical application.
Their services span the 'bench to bedside' continuum, facilitating the transition of scientific breakthroughs.
VectorB2B acts as a research organization dedicated to advancing drug discovery and development initiatives.

About VectorB2B - Drug Development

VectorB2B is a Portuguese non-profit association and research organization established to accelerate science through specialized pre-clinical and clinical development services. It supports companies throughout their R&D journey, providing drug discovery and development services from bench to bedside (B2B).

Leadership Team

Ana Custódio

Co-CEO

Tip: The CEO isn't always your best path in. Data Surfer finds the champions and influencers who actually drive purchasing decisions.

Company Facts

Ownership Private Company

Why Contact VectorB2B - Drug Development?

VectorB2B is a full-service Contract Research Organization (CRO) that provides specialized pre-clinical and clinical development services, supporting drug discovery and development from discovery to c

Who Should Contact VectorB2B - Drug Development for Business?

Full-service Contract Research Organization (CRO) providing specialized pre-clinical and clinical development services.

Frequently Asked Questions

Who is the CEO of VectorB2B - Drug Development?: Ana Custódio serves as the Co-CEO of VectorB2B.
What does VectorB2B - Drug Development do?: VectorB2B is a full-service Contract Research Organization (CRO) that provides specialized pre-clinical and clinical development services, supporting drug discovery and development from discovery to clinical trials.
How many employees does VectorB2B - Drug Development have?: VectorB2B has a team of more than 15 people.
Where is VectorB2B - Drug Development headquartered?: VectorB2B is located in Portugal.
What industry is VectorB2B - Drug Development in?: VectorB2B - Drug Development operates in Biotechnology / Drug Development.
When was VectorB2B - Drug Development founded?: VectorB2B - Drug Development was founded in 2019.
Is VectorB2B - Drug Development still active?: Yes, VectorB2B - Drug Development was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
How do I sell to VectorB2B - Drug Development?: Research VectorB2B - Drug Development's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.